MNPR
Monopar Therapeutics·NASDAQ
--
--(--)
--
--(--)
MNPR fundamentals
Monopar Therapeutics (MNPR) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.35 (YoY +30.00%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.35
+30.00%
Report date
Aug 12, 2025
Earnings Call
8:15 AM on Aug 12, 2025
Meeting link.EPS
Actual | -0.5 | -0.7 | -0.75 | -0.95 | -0.8 | -0.85 | -1 | -1.05 | -0.95 | -1.1 | -0.95 | -1.15 | -0.95 | -0.8 | -0.7 | -0.6 | -0.5 | -0.5 | -0.37 | -2.74 | -0.38 | -0.35 | |
Forecast | -0.55 | -0.85 | -0.7833 | -0.925 | -0.9333 | -0.9375 | -1.02 | -0.97 | -1.04 | -1.0333 | -1.0833 | -1.025 | -1.11 | -0.92 | -0.7667 | -0.8167 | -0.725 | -0.5 | -0.995 | -0.378 | -0.68 | -0.4583 | |
Surprise | 0.00% | +9.09% | +17.65% | +4.25% | -2.70% | +14.28% | +9.33% | +1.96% | -8.25% | +8.65% | -6.46% | +12.30% | -12.20% | +14.41% | +13.04% | +8.70% | +26.53% | +31.03% | 0.00% | +62.81% | -624.87% | +44.12% | +23.63% |
Revenue
Actual | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What does Monopar Therapeutics do and what are its main business segments?What were the key takeaways from Monopar Therapeutics's earnings call?What is the market's earnings forecast for Monopar Therapeutics next quarter?What factors drove the changes in Monopar Therapeutics's revenue and profit?What guidance did Monopar Therapeutics's management provide for the next earnings period?What is Monopar Therapeutics's gross profit margin?What were the key takeaways from Monopar Therapeutics’s earnings call?What is the revenue and EPS growth rate for Monopar Therapeutics year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
